Producto añadido correctamente al carrito.

discount label
H-LVLQTM-OH
Ver en 3D

Biosynth logo

H-LVLQTM-OH

Ref. 3D-PP49091

1mg
189,00 €
10mg
195,00 €
100mg
349,00 €
Entrega estimada en Estados Unidos, el Viernes 27 de Diciembre de 2024

Información del producto

Nombre:
H-LVLQTM-OH
Descripción:

Peptide H-LVLQTM-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LVLQTM-OH include the following: Hand, Foot, and Mouth Disease Challenges and Its Antiviral Therapeutics Z Li, W Ji, S Chen, G Duan, Y Jin - Vaccines, 2023 - mdpi.comhttps://www.mdpi.com/2076-393X/11/3/571 Recent advances in enterovirus A71 infection and antiviral agents Y Wei, H Liu, D Hu, Q He, C Yao, H Li, K Hu - Laboratory , 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0023683723002416 Structures and corresponding functions of five types of picornaviral 2A proteins X Yang, A Cheng, M Wang, R Jia, K Sun - Frontiers in , 2017 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fmicb.2017.01373/full Antiviral molecules of enteroviruses V Saarnio - 2017 - jyx.jyu.fihttps://jyx.jyu.fi/handle/123456789/52777 Efficient strategy to design protease inhibitors: Application to enterovirus 71 2A protease T Chen , C Grauffel, WZ Yang, YP Chen - ACS bio & med , 2022 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsbiomedchemau.2c00001 Advances in anti-EV71 drug development research S Wanga, Z Panga, H Fana, Y Tongab - researchgate.nethttps://www.researchgate.net/profile/Huahao-Fan/publication/369413384_Advances_in_anti-EV71_drug_development_research/links/6428d70b315dfb4ccec6e627/Advances-in-anti-EV-A71-drug-development-research.pdf Molecular mechanism of L-SP40 peptide and in vivo efficacy against EV-A71 in neonatal mice S Lalani , SH Tan , KO Tan , HX Lim , KC Ong , KT Wong - Life Sciences, 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0024320521010845 Antiviral peptides against Enterovirus A71 causing hand, foot and mouth disease S Lalani , LT Gew , CL Poh - Peptides, 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0196978120301923 Identifying novel antiviral targets against enterovirus 71: where are we? S Gunaseelan, JJH Chu - Future Virology, 2017 - Future Medicinehttps://www.futuremedicine.com/doi/abs/10.2217/fvl-2016-0144 Insight into the Enterovirus A71: A review R Kinobe , A Wiyatno, IM Artika - Reviews in medical , 2022 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/rmv.2361 EV-A71 Infections: Life Cycle and Prevention Strategies QL Tu, TT Nguyen , TT Tran, NHV Vo - VNU Journal of Science , 2023 - js.vnu.edu.vnhttps://js.vnu.edu.vn/NST/article/view/5288 Update on enterovirus 71 infection PN Huang , SR Shih - Current opinion in virology, 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1879625714000674 Suramin interacts with the positively charged region surrounding the 5-fold axis of the EV-A71 capsid and inhibits multiple enterovirus A P Ren, Y Zheng, W Wang, L Hong, F Delpeyroux - Scientific reports, 2017 - nature.comhttps://www.nature.com/articles/srep42902 Ex Vivo and In Vivo Inhibition of Human Rhinovirus Replication by a New Pseudosubstrate of Viral 2A Protease N Falah, S Violot, D Decimo, F Berri - Journal of , 2012 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.05263-11 Blocking human enterovirus 71 replication by targeting viral 2A protease N Falah, R Montserret, V Lelogeais - Journal of , 2012 - academic.oup.comhttps://academic.oup.com/jac/article-abstract/67/12/2865/775113 Antivirals blocking entry of enteroviruses and therapeutic potential MI Anasir , F Zarif, CL Poh - Journal of biomedical science, 2021 - Springerhttps://link.springer.com/article/10.1186/S12929-021-00708-8 Sulfonated Azo Dyes Interact with Capsid of Human Enterovirus 71 to Modulate the Viral Infectivity, and Their Implication on the Viral Vaccine Design M Tao - 2019 - search.proquest.comhttps://search.proquest.com/openview/b195bfc7a1efd3b0e74d9187c7df31e2/1?pq-origsite=gscholar&cbl=2026366&diss=y Identification and characterization of new small molecule inhibitors of picornavirus replication LAF Siltz - 2016 - search.proquest.comhttps://search.proquest.com/openview/57c1b25bd6af0fb5a1a321939664ba6a/1?pq-origsite=gscholar&cbl=18750 Antiviral drug discovery for the treatment of enterovirus 71 infections L Shang, M Xu, Z Yin - Antiviral research, 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0166354212002859 Antivirals and vaccines for Enterovirus A71 L Jing-Yi, K Yu-An, SR Shih - Journal of Biomedical Science, 2019 - search.proquest.comhttps://search.proquest.com/openview/ff276e11ea33042622b4310da4b8f5a5/1?pq-origsite=gscholar&cbl=54111 Enzymes and enzyme activity encoded by nonenveloped viruses K Azad, M Banerjee, JE Johnson - Annual Review of Virology, 2017 - annualreviews.orghttps://www.annualreviews.org/doi/abs/10.1146/annurev-virology-101416-041944 Antivirals and vaccines for Enterovirus A71 JY Lin, YA Kung, SR Shih - Journal of biomedical science, 2019 - Springerhttps://link.springer.com/article/10.1186/s12929-019-0560-7 RNA-virus proteases counteracting host innate immunity J Lei , R Hilgenfeld - FEBS letters, 2017 - Wiley Online Libraryhttps://febs.onlinelibrary.wiley.com/doi/abs/10.1002/1873-3468.12827 Development of antiviral agents toward enterovirus 71 infection HR Pourianfar , L Grollo - Journal of Microbiology, Immunology and , 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1684118213002363 Enteroviruses and rhinoviruses G Wang - Molecular Medical Microbiology, 2024 - Elsevierhttps://www.sciencedirect.com/science/article/pii/B9780128186190000629 Antimicrobial peptides and their potential application in antiviral coating agents ED Freitas , RA Bataglioli , J Oshodi - Colloids and Surfaces B , 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0927776522003769 Recent developments in antiviral agents against enterovirus 71 infection CW Tan , JKF Lai, IC Sam , YF Chan - Journal of biomedical science, 2014 - Springerhttps://link.springer.com/article/10.1186/1423-0127-21-14 Strategies to identify and develop antiviral peptides CL Poh , S Lalani - Vitamins and Hormones, 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0083672921000522 Development and characterization of a stable eGFP enterovirus 71 for antiviral screening B Shang, C Deng, H Ye, W Xu, Z Yuan, PY Shi - Antiviral research, 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0166354212002902

Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:

Propiedades químicas

MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:

Información de peligrosidad

Número UN:
Cantidad exceptuada (EQ):
Clase:
Frases H:
Frases P:
Prohibido volar:
Información de peligrosidad:
Grupo de empaquetado:
Cantidad limitada (LQ):

Consulta técnica sobre: 3D-PP49091 H-LVLQTM-OH

Use el carrito para solicitar presupuestos o pedidos

Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.

* Campos obligatorios
¡Bienvenido a CymitQuimica!Utilizamos cookies para mejorar su visita. No incluimos publicidad.

Consulte nuestra Política de Cookies para obtener más información o ajuste sus preferencias en "Configurar".